YPEL4

YPEL4 is a Yippee-domain protein that functions in MAPK/ERK signaling and contributes to cell proliferation and red cell membrane integrity. It binds the Major Vault Protein (MVP) and activates the transcription factor Elk-1, an activity that MVP suppresses upon binding (PMID:20555386). Consistent with a pro-proliferative role, overexpression of YPEL4 in adrenocortical HAC15 cells stimulates proliferation and increases basal aldosterone production (PMID:27333825). In vivo, YPEL4 is required for normal erythrocyte biology: Ypel4-null mice develop secondary polycythemia with reticulocytosis, and their red blood cells show reduced deformability, ovalocytic morphology, reduced membrane Band 3 levels, and increased clearance from circulation, establishing an intrinsic role in red cell membrane integrity that does not depend on a direct YPEL4–Band 3 interaction (PMID:34354145). Beyond these findings, the molecular mechanism linking YPEL4 to its cellular phenotypes has not been characterized in the available corpus.

1. 2010 Medium

   Established the first molecular partner and signaling readout for YPEL4 by showing it activates Elk-1 in the MAPK/ERK pathway and that this is gated by MVP binding.

   Evidence Yeast and mammalian two-hybrid, GST pull-down, co-immunoprecipitation, immunocytochemistry and Elk-1 reporter assay

   PMID:20555386

   Open questions at the time

   • Mechanism by which YPEL4 activates Elk-1 (direct vs indirect) not resolved
   • How MVP binding physically blocks the activity is unknown
   • No endogenous-level validation of the interaction or pathway
2. 2016 Medium

   Linked YPEL4 to a concrete cellular phenotype by showing its overexpression drives adrenocortical proliferation and aldosterone output.

   Evidence Overexpression in HAC15 cells with XTT, crystal violet, and aldosterone measurement

   PMID:27333825

   Open questions at the time

   • No pathway placement connecting proliferation to the Elk-1/MVP axis
   • Loss-of-function in this system not tested
   • Mechanism of aldosterone induction unknown
3. 2021 Medium

   Demonstrated an essential in vivo role for YPEL4 in red blood cell membrane integrity through a knockout mouse.

   Evidence Ypel4-null mouse with scanning electron microscopy, deformability assays, in vivo clearance, and membrane protein analysis

   PMID:34354145

   Open questions at the time

   • Molecular mechanism linking YPEL4 loss to reduced Band 3 not defined
   • Direct YPEL4–Band 3 interaction explicitly not supported
   • Relationship to the Elk-1/MVP/proliferation role not established
4. 2023 Low

   Identified YPEL4 overexpression as selectively cytotoxic to transformed cells, hinting at a context-dependent pro-death activity.

   Evidence Gain-of-function forward genetic screen with cell death readout in mammalian cells

   PMID:37864183

   Open questions at the time

   • Single screen with no YPEL4-specific mechanistic follow-up
   • Pathway mediating selective death in transformed cells unknown
   • Apparent contradiction with pro-proliferative role unresolved

• The unifying molecular mechanism connecting YPEL4's Elk-1 activation, proliferative effects, and erythrocyte membrane role remains undefined.
• No structural or biochemical basis for YPEL4 activity
• No direct substrate or downstream effector identified
• Mechanism controlling Band 3 levels in RBC membranes unknown